773 results on '"Thota, Prashanthi N."'
Search Results
102. 157 NEOPLASTIC PROGRESSION OF BARRETT'S ESOPHAGUS AMONG ORGAN TRANSPLANT RECIPIENTS: A CASE-CONTROL STUDY
103. Tu1271 A TISSUE SYSTEMS PATHOLOGY TEST ENABLES STANDARDIZED, RISK-ALIGNED MANAGEMENT OF PATIENTS WITH BARRETT'S ESOPHAGUS
104. Mo1283 PATIENTS WITH ESOPHAGEAL ACHALASIA ARE AT A HIGHER RISK OF AUTOIMMUNE DISEASES THAN GENERAL POPULATION: A NATIONAL DATABASE STUDY
105. Sa1296 FACTORS ASSOCIATED WITH PERSISTENT ESOPHAGEAL SYMPTOMS IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS POST HISTOLOGICAL REMISSION
106. 222 A TISSUE SYSTEMS PATHOLOGY TEST OUTPERFORMS STANDARD CLINICOPATHOLOGIC VARIABLES IN PREDICTING PROGRESSION IN PATIENTS WITH BARRETT'S ESOPHAGUS.
107. Higher risk of neoplastic progression of Barrett’s esophagus in patients with systemic sclerosis
108. Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma
109. Chemoprevention in Barrett’s esophagus and esophageal adenocarcinoma
110. Recent advances in third space or intramural endoscopy
111. Barrett's Esophagus in Rubinstein-Taybi Syndrome
112. S0389 Comparison of the Risk Factor Profile of Adenocarcinomas of the Esophagogastric Junction (EGJ) and Non-Junctional Esophageal Adenocarcinomas (EAC): A National Database Study
113. S0432 Men With Metabolic Syndrome Are at Increased Risk of Urogenital Cancers Among Patients With Barrett's Esophagus
114. S0433 Risk of Extra-Esophageal Malignancies in Patients With Barrett's Esophagus
115. Clinical Success and Correlation of Eckardt Scores with Barium Esophagram After Peroral Endoscopic Myotomy in Achalasia
116. A Curious Case of Bloody Diarrhea
117. Changes in esophageal physiology after paraesophageal hernia repair and Collis gastroplasty
118. Peroral Endoscopic Myotomy Is Safe and Highly Effective Treatment for Advanced Achalasia With Sigmoid Esophagus
119. Pyloroplasty and the risk of Barrett’s esophagus in patients with gastroparesis
120. Peroral endoscopic myotomy is highly effective for achalasia patients with recurrent symptoms after pneumatic dilatation
121. Sa1277 PERORAL ENDOSCOPIC MYOTOMY IS AN EQUALLY SAFE AND HIGHLY EFFECTIVE TREATMENT OPTION IN ACHALASIA PATIENTS WITH BOTH LOWER AND HIGHER ASA CLASSIFICATION STATUS
122. Sa1276 PERORAL ENDOSCOPIC MYOTOMY IS HIGHLY EFFICACIOUS FOR ADVANCED ACHALASIA PATIENTS WITH SIGMOID ESOPHAGUS
123. Mo1254 PREVALENCE AND PREDICTORS OF INTESTINAL METAPLASIA IN PATIENTS WITH IRREGULAR Z LINE
124. Tu1560 GASTRIC PERORAL ENDOSCOPIC MYOTOMY OR PERORAL PYLOROMYOTOMY IS HIGHLY EFFECTIVE FOR POSTSURGICAL GASTROPARESIS
125. Sa1310 DO PROTON PUMP INHIBITORS DECREASE THE RISK OF RESPIRATORY TRACT CANCERS IN PATIENTS WITH BARRETT’S ESOPHAGUS?
126. National trends in healthcare outcomes and utilization of endoscopic and surgical interventions in patients hospitalized with esophageal foreign body and food impaction
127. Sa1203 PREDICTION OF NEOPLASTIC PROGRESSION IN BARRETT'S ESOPHAGUS BY PATHOLOGIC ASSESSMENT OF DEGREE OF CRYPT ATYPIA AND BY TISSUECYPHER
128. Su1767 FACTORS ASSOCIATED WITH BARRETT'S ESOPHAGUS IN PATIENTS WITH GASTROPARESIS
129. Sa1675 STATINS REDUCE THE RISK OF ALL CANCERS IN PATIENTS WITH BARRETT'S ESOPHAGUS
130. Mo1306 HIGH GRADE DYSPLASIA (HGD) AND ESOPHAGEAL ADENOCARCINOMA (EAC) RARELY OCCUR IN PATIENTS WITH IRREGULAR Z LINE
131. Sa1202 TOLERABILITY OF A NON-ENDOSCOPIC DISTAL ESOPHAGUS SAMPLING DEVICE
132. Tu1319 THE EPIDEMIOLOGY OF BARRETT'S ESOPHAGUS IN CHRONIC KIDNEY DISEASE IN THE UNITED STATES: A POPULATION BASED STUDY
133. GERD: A practical approach
134. Obesity Does Not Impact Outcomes or Rates of Gastroesophageal Reflux After Peroral Endoscopic Myotomy in Achalasia
135. Independent Blinded Validation of a Tissue Systems Pathology Test to Predict Progression in Patients With Barrett's Esophagus
136. In reply: Barrett esophagus: Definition, treatment
137. Adenomas Are Detected More Often in Morning Than in Afternoon Colonoscopy
138. Barrett’s Esophagus in Women: Demographic Features and Progression to High-Grade Dysplasia and Cancer
139. Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors
140. Trends and risk factors for 30-day readmissions in patients with acute cholangitis: analysis from the national readmission database
141. Indications, contraindications and limitations of endoscopic therapy for Barrett’s esophagus and early esophageal adenocarcinoma
142. 392 THE TISSUE SYSTEMS PATHOLOGY TEST ENABLES RISK-ALIGNED MANAGEMENT FOR PATIENTS WITH BARRETT'S ESOPHAGUS.
143. Esophageal dysmotility and other preoperative factors associated with acid suppressive therapy after fundoplication
144. Current management of Barrett esophagus and esophageal adenocarcinoma
145. Resection of early esophageal neoplasms: The pendulum swings from surgical to endoscopic management
146. 435 Trends and Correlation Between Eckardt Scores and Timed Barium Esophagram Parameters After Per-Oral Endoscopic Myotomy in Achalasia
147. 436 Peroral Endoscopic Myotomy Is a Safe and Effective Treatment Modality for Achalasia After Prior Failed Botulinum Toxin Treatment
148. 152 Fair Colonoscopy Bowel Preparation Is Not Adequate for Effective Colonoscopy
149. 2856 The Epidemiology of Barrett’s Esophagus in Chronic Kidney Disease in the U.S.: A Population-Based Study
150. 354 Cumulative Increase in the Prevalence of Esophageal Cancer in Patients With Gastroesophageal Reflux Disease (GERD) and Multiple Risk Factors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.